Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement

A G Togias, R M Naclerio, D Proud, J E Fish, N F Adkinson Jr, A Kagey-Sobotka, P S Norman, L M Lichtenstein, A G Togias, R M Naclerio, D Proud, J E Fish, N F Adkinson Jr, A Kagey-Sobotka, P S Norman, L M Lichtenstein

Abstract

The purpose of our study was to assess the effect of cold, dry air (CDA) on the nasal mucosa of selected individuals in relation to the release of inflammatory mediators associated with mast cells. 12 subjects with a history of nasal symptoms of rhinorrhea and congestion upon cold or dry environmental exposure were challenged by nasal breathing of CDA and warm, moist air (WMA). Each subject was tested on two occasions with the order of the challenges reversed. Symptom scores were recorded, and the levels of histamine, prostaglandin (PG) D2, kinins, and [3H]-N-alpha-tosyl-L-arginine methyl ester (TAME)-esterase activity in nasal lavage fluids were measured. CDA caused a significant increase in mediator levels and in symptom scores as compared to baseline or to WMA. No significant increase in symptom scores or mediators was noted after WMA challenge, with the exception of a marginal increase in kinins. The response to CDA was similar, regardless of challenge order. Changes in mediators correlated with one another, and symptom scores correlated significantly with the levels of histamine, kinins, and PGD2. Five subjects without a history of nasal symptoms on cold air exposure had no change in mediators or symptom scores after CDA or WMA challenge. We conclude that CDA causes the release of inflammatory mediators possibly associated with mast cells and speculate that such a mechanism may be involved in the bronchospasm induced by CDA in asthmatics.

References

    1. Laryngoscope. 1981 Oct;91(10):1600-5
    1. Clin Sci (Lond). 1981 Aug;61(2):159-62
    1. Br Med J (Clin Res Ed). 1981 Nov 14;283(6302):1285-7
    1. J Biol Chem. 1981 Nov 25;256(22):11939-43
    1. J Clin Invest. 1982 Apr;69(4):889-99
    1. J Allergy Clin Immunol. 1982 Aug;70(2):73-81
    1. J Clin Invest. 1982 Oct;70(4):747-51
    1. Clin Allergy. 1982 Oct;12 Suppl:29-37
    1. Eur J Respir Dis. 1982 Sep;63(5):459-71
    1. Lancet. 1983 Mar 5;1(8323):520-2
    1. Eur J Respir Dis Suppl. 1983;128 (Pt 1):26-32
    1. J Immunol. 1983 Oct;131(4):1936-41
    1. Am Rev Respir Dis. 1983 Oct;128(4):597-602
    1. J Clin Invest. 1983 Nov;72(5):1678-85
    1. J Allergy Clin Immunol. 1984 Mar;73(3):391-9
    1. Am Rev Respir Dis. 1984 Mar;129(3):409-12
    1. N Engl J Med. 1984 Jun 21;310(25):1626-30
    1. Am Rev Respir Dis. 1984 Jul;130(1):86-91
    1. J Exp Med. 1964 Oct 1;120:507-30
    1. Ann Otol Rhinol Laryngol. 1969 Feb;78(1):40-8
    1. Ann Otol Rhinol Laryngol. 1971 Oct;80(5):736-43
    1. J Immunol. 1975 Mar;114(3):1101-6
    1. J Immunol. 1976 Mar;116(3):639-46
    1. Am Rev Respir Dis. 1976 Oct;114(4):739-52
    1. J Allergy Clin Immunol. 1976 Nov;58(5):563-74
    1. Prostaglandins. 1977 Feb;13(2):225-34
    1. J Immunol. 1977 Dec;119(6):2078-83
    1. J Lab Clin Med. 1977 Dec;90(6):1043-53
    1. Prostaglandins. 1977 Oct;14(4):633-43
    1. J Appl Physiol Respir Environ Exerc Physiol. 1979 Mar;46(3):467-75
    1. J Lipid Res. 1979 Jan;20(1):116-24
    1. J Clin Invest. 1979 Aug;64(2):457-65
    1. J Clin Invest. 1979 Sep;64(3):804-11
    1. Clin Allergy. 1979 Sep;9(5):437-41
    1. J Clin Invest. 1980 Mar;65(3):659-65
    1. J Allergy Clin Immunol. 1980 Oct;66(4):295-8
    1. J Clin Invest. 1980 Nov;66(5):1072-80
    1. J Allergy Clin Immunol. 1980 Dec;66(6):472-7
    1. J Allergy Clin Immunol. 1981 Apr;67(4):253-62
    1. J Clin Invest. 1981 Jun;67(6):1604-13
    1. Am Rev Respir Dis. 1981 Oct;124(4):402-6

Source: PubMed

3
订阅